[Progress in clinical research related to viral hepatitis in 2025]. [PDF]
Ding Y, Li Y, Dou XG.
europepmc +1 more source
[Efficacy and Safety of High-dose Furmonertinib plus Intrathecal Pemetrexed for EGFR-mutant Non-small Cell Lung Cancer with Leptomeningeal Metastasis]. [PDF]
Chen X +11 more
europepmc +1 more source
[Rapid determination of venetoclax in plasma by ultra performance liquid chromatography-tandem mass spectrometry]. [PDF]
Zhu Y, Ma XL, Yu SL, Qiu L.
europepmc +1 more source
[Research progress in liver cancer in 2025]. [PDF]
Miao TG, Nan YM.
europepmc +1 more source
[Clinical characteristics, efficacy and safety of antifibrotic agents in elderly patients with connective tissue disease-associated interstitial lung disease]. [PDF]
Lan J, Chen Z, Cheng Y, Zhao L.
europepmc +1 more source
[Research Progress on Microbiome-Driven Mechanisms and Intervention Strategies for Oral Malodor]. [PDF]
Shang X, Wang Z, Ge S.
europepmc +1 more source
[SERPINE1 overexpression promotes proliferation and paclitaxel resistance of triple-negative breast cancer cells by inducing M2 macrophage polarization]. [PDF]
Zhang Q +10 more
europepmc +1 more source
[Molecular Epidemiology and Fluconazole Resistance Mechanisms in <i>Candida tropicalis</i> Isolates From Bloodstream Infections in Sichuan, China]. [PDF]
Chen W, Hou J, Peng L, Kang M, Ma Y.
europepmc +1 more source
[Integrative Analysis of Multi-source Public Databases to Screen Core Genes for Constructing A Prognostic Risk Model in Lung Adenocarcinoma]. [PDF]
Wang C +4 more
europepmc +1 more source
[Value of gene mutation in the prognosis and treatment of multiple myeloma]. [PDF]
Cheng LL, Zhuang JL.
europepmc +1 more source

